INSPECS Group plc Share Price
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
16:35:18 10/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 96.00 GBX | 0.00% |
|
0.00% | +34.27% |
| 09-10 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 09-10 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 142M 122M 115M 105M 196M 13.53B 198M 1.37B 528M 6.89B 532M 521M 21.91B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 97.71M 84.17M 79.47M 72.33M 135M 9.33B 136M 946M 364M 4.75B 367M 359M 15.1B | EV / Sales 2026 * |
0.37x | EV / Sales 2027 * | 0.35x |
| Free-Float |
10.73% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 03-04 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-11 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-09 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 01-27 | Form 8.3 - Inspecs Group Plc | AQ |
| 01-07 | Form 8.3 - Inspecs Group Plc | AQ |
| 1 month | -1.03% | ||
| 3 months | +13.61% | ||
| 6 months | +15.66% | ||
| Current year | +34.27% |
| 1 week | 92.62 |  | 100 |
| 1 month | 92 | | 100 |
| Current year | 60 | | 105 |
| 1 year | 38.05 | | 105 |
| 3 years | 37 | | 105.85 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 30/11/2022 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Peck
BRD | Director/Board Member | 62 | 09/01/2020 |
Angela Farrugia
BRD | Director/Board Member | 61 | 11/05/2020 |
Luke Johnson
BRD | Director/Board Member | 64 | 18/05/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/06/25 | Free | Chief Executive Officer | 250,000 | 0.2459% | ||
| 04/06/25 | Free | Chief Executive Officer | 150,000 | 0.1475% | ||
| 08/11/22 | Buy | Chief Executive Officer | 833,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +123.26% | -9.43% | 142M | |
| -2.11% | -8.10% | -43.90% | -15.86% | 79.58B | |
| -2.50% | -8.19% | -13.55% | -25.95% | 33.35B | |
| -0.09% | +3.65% | - | - | 12.68B | |
| -14.67% | -22.31% | -20.63% | -38.09% | 12.38B | |
| -3.67% | -0.19% | -1.80% | +602.81% | 2.72B | |
| -1.38% | -2.55% | -40.35% | -58.81% | 1.45B | |
| -0.69% | -3.43% | - | - | 920M | |
| -1.74% | -6.98% | +14.89% | 0.00% | 909M | |
| -1.11% | -6.97% | -37.24% | -23.48% | 865M | |
| Average | -2.80% | -2.89% | -2.42% | +53.90% | 14.5B | |
| Weighted average by Cap. | -3.10% | -5.17% | -32.46% | -8.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 230M 217M 198M 370M 25.5B 373M 2.59B 995M 12.98B 1B 981M 41.29B | 277M 238M 225M 205M 383M 26.41B 386M 2.68B 1.03B 13.44B 1.04B 1.02B 42.77B |
| Net income | - | - |
| Net Debt | -44.08M -37.97M -35.85M -32.63M -60.99M -4.21B -61.56M -427M -164M -2.14B -166M -162M -6.81B | -45.44M -39.14M -36.96M -33.64M -62.87M -4.34B -63.46M -440M -169M -2.21B -171M -167M -7.02B |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | GBX 96.00 | 0.00% | 0 |
| 09/09/26 | GBX 96.00 | 0.00% | 1 |
| 08/09/26 | GBX 96.00 | 0.00% | 1,030 |
| 07/09/26 | GBX 96.00 | 0.00% | 504 |
| 04/09/26 | GBX 96.00 | 0.00% | 0 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.299USD
Average target price
0.8180USD
Spread / Average Target
-37.01%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
